Tag: LINC 2025
Addressing barriers to pAVF adoption with next-generation devices
Robert Shahverdyan (Hamburg, Germany) writes for Vascular News on the technologies shaping the future of the field of percutaneous arteriovenous fistula (AVF) creation for...
MedTech Insights: Abbott’s AmpuNATION campaign ‘a wake-up call for all stakeholders,’...
A new initiative from Abbott hopes to increase awareness of peripheral arterial disease (PAD) in the UK with the aim of preventing unnecessary amputations....
Two-year iVolution Pro registry data presented at LINC 2025
iVascular has shared that Mariano Palena (Policlinico Abano Terme, Abano Terme, Italy) presented the results of an observational and prospective registry on the use...
TINTIN trial subanalyses presented at LINC 2025
Koen Deloose (AZ Sint Blasius Hospital, Dendermonde, Belgium) presented new sub-cohort analyses from the TINTIN trial at this year's Leipzig Interventional Course (LINC 2025;...
Data and device tweaks herald ‘practice-changing’ future for bioabsorbable scaffolds
Pending the results of several trials and “iterative changes” to device design, bioabsorbable scaffolds are set to change the treatment paradigm for lower extremity...
Bentley announces FEVAR indication for BeGraft and launch of new BeFlared...
After the official launch of the BeFlow earlier this week, Bentley has announced that it successfully launched two additional products at the Leipzig Interventional...
Drug-eluting technologies should be ‘de facto standard of care’ for PAD,...
New data from a large, real-world study support the use of drug-eluting devices to reduce amputations, readmissions, and healthcare costs in the treatment of...
Bentley launches BeFlow iliac covered stent system at LINC 2025
Bentley today announced the market launch of its BeFlow iliac covered stent system at the Leipzig Interventional Course (LINC 2025; 28–30 January, Leipzig, Germany)....
